Clinical trial Recruiting at 1 site Interventional Ages 18 to 59

Brain stimulation plus watching hand movements to improve hand recovery after chronic stroke

Official title: Investigating The Neurophysiological Mechanisms Of Transcranial Direct Current Stimulation Combined With Action Observation Therapy On Hand Muscle Neuroplasticity in Chronic Stroke

Run by Universiti Malaysia Sabah · NCT07400939 · Data updated 2026-11-12

This project will test whether combining gentle brain stimulation with watching and practicing hand movements helps adults 6–24 months after stroke improve hand function.

Quick facts

Study typeInterventional
Ages18 Years to 59 Years
SexAll
Enrollment60 (estimated)
SponsorUniversiti Malaysia Sabah
Academic / other
Locations2 sites (Kota Kinabalu, Sabah and 1 other locations)
StatusRecruiting
StartedApril 1, 2026
Main results expectedJanuary 20, 2027
Study endsJanuary 20, 2028
Registry record updatedMay 12, 2026
Trial IDNCT07400939 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–59 with a single unilateral stroke 6–24 months ago who have hand weakness but only mild or less upper-limb spasticity and can follow commands are ideal candidates.

Probably not a fit

Patients with posterior circulation strokes, severe cognitive impairment, unilateral neglect, homonymous hemianopia, other neurological conditions affecting the hand, or near-normal/very weak (grade 4–5) hand strength are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants will receive ten sessions of anodal transcranial direct current stimulation (tDCS) over the affected motor cortex combined with supervised action observation therapy (AOT) in clinic over two weeks, followed by eight weeks of daily home-based AOT practice. Two control groups receive either tDCS with a landscape video or AOT with placebo tDCS on the same schedule, allowing comparison of the combined approach to each therapy alone. Neurophysiological changes will be tracked using motor evoked potentials (MEPs) to measure corticospinal excitability and standard clinical tests will measure hand function. Total participation lasts about ten weeks including baseline and follow-up assessments.

Why it matters

Potential benefit: If successful, the combined approach could improve corticospinal excitability and translate into better hand function and everyday use for people with chronic stroke.

How similar studies have gone: Previous studies have shown modest benefits from tDCS or action observation therapy alone, but combining them is relatively novel and not yet proven to be superior.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 to 59 years
* Single episode of unilateral stroke and weakness in hand muscles 6 to 24 months post-stroke
* No excessive spasticity of the upper limb, defined as grade two or less on Modified Ashworth Scale

Exclusion Criteria:

* Patients diagnosed with posterior circulation infarction
* Unable to follow commands due to poor cognitive function
* Unilateral neglect
* Homonymous hemianopia
* Other existing neurological disorders that lead to poor hand function
* Grade four or five hand muscle strength.

Where it's running

  • Hospital Universiti Malaysia Sabah (HUMS)
    Kota Kinabalu, Sabah, Malaysia
    Recruiting
  • Queen Elizabeth Hospital
    Kota Kinabalu, Sabah, Malaysia
    Enrolling by invitation

Study contacts

  • Principal investigator: Fatimah Ahmedy — Universit Malaysia Sabah
  • Study coordinator: Candace Goh Xiao Huey, Msc.
  • Email: candace@moh.gov.my
  • Phone: +60-162316345

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.